Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Winzeler

Showing results (111-120 of 223) with videos related to

Pageof 23
Sort By:
ACS Chemical Biology|October 17, 2014
Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarialsErika L Flannery, Case W McNamara, Sang Wan Kim, et al.
European Journal of Medicinal Chemistry|June 7, 2014
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesFinn K Hansen, Subathdrage D M Sumanadasa, Katharina Stenzel, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
Mbio|February 9, 2017
Selective Whole-Genome Amplification Is a Robust Method That Enables Scalable Whole-Genome Sequencing of Plasmodium vivax from Unprocessed Clinical SamplesAnnie N Cowell, Dorothy E Loy, Sesh A Sundararaman, et al.
Cell Chemical Biology|October 8, 2025
Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitorsSelina Bopp, Lọla Fagbami, Amy Deik, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing <i>N</i>-Methyl Amino Acids as Antiplasmodial AgentsCatherine Fagundez, Diver Sellanes, Stella Peña, et al.
Plos Genetics|February 15, 2013
Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesSelina E R Bopp, Micah J Manary, A Taylor Bright, et al.
The Journal of Experimental Medicine|June 30, 2010
The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glandsMin Zhang, Clare Fennell, Lisa Ranford-Cartwright, et al.
Molecular Microbiology|April 14, 2016
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugsCaroline L Ng, Giulia Siciliano, Marcus C S Lee, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Pageof 23

Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
ACS Chemical Biology|October 17, 2014
Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarialsErika L Flannery, Case W McNamara, Sang Wan Kim, et al.
European Journal of Medicinal Chemistry|June 7, 2014
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesFinn K Hansen, Subathdrage D M Sumanadasa, Katharina Stenzel, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
Mbio|February 9, 2017
Selective Whole-Genome Amplification Is a Robust Method That Enables Scalable Whole-Genome Sequencing of Plasmodium vivax from Unprocessed Clinical SamplesAnnie N Cowell, Dorothy E Loy, Sesh A Sundararaman, et al.
Cell Chemical Biology|October 8, 2025
Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitorsSelina Bopp, Lọla Fagbami, Amy Deik, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing <i>N</i>-Methyl Amino Acids as Antiplasmodial AgentsCatherine Fagundez, Diver Sellanes, Stella Peña, et al.
Plos Genetics|February 15, 2013
Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesSelina E R Bopp, Micah J Manary, A Taylor Bright, et al.
The Journal of Experimental Medicine|June 30, 2010
The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glandsMin Zhang, Clare Fennell, Lisa Ranford-Cartwright, et al.
Molecular Microbiology|April 14, 2016
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugsCaroline L Ng, Giulia Siciliano, Marcus C S Lee, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Pageof 23